Printer Friendly

BIOPOOL EXTENDS WARRANTS

 VENTURA, Calif., March 25 /PRNewswire/ -- Biopool International Inc. (NASDAQ: BIPL) announced today it will extend the expiration date of its Class A and Class B warrants to Dec. 31, 1993 from May 2, 1993.
 As part of its initial public offering in 1988, Biopool issued 1 million units, consisting of three shares of common stock and three redeemable Class A warrants. Each Class A warrant entitles the holder to purchase one share of the company's common stock for $3.25 and to receive one Class B warrant until May 2, 1993. Each Class B warrant entitles the holder to purchase one share of the company's common stock for $5.00 until May 2, 1993. The Class A and Class B warrants are redeemable at $.05 per warrant at the option of the company if certain quoted market prices are achieved by the common stock. Michael D. Bick, Ph.D., chief executive officer, said the extension of the expiration date of the warrants is a "one-time only" extension, and there will be no additional extensions after Dec. 31, 1993.
 Founded in 1987, Biopool develops, manufactures and markets a full range of test kits to assess and diagnose disorders of blood coagulation, fibrinolysis, platelet function and the vascular system, as well as test kits to determine thrombotic risk factors. The company's products are sold to hospitals and clinical laboratories worldwide.
 -0- 3/25/93
 /CONTACT: Michael D. Bick, Ph.D., CEO, 805-654-0643, or (Canada) Andrew L. Cerskus, Ph.D., president, 416-332-9419, both of Biopool International; or Kim P. Feazle or Roger S. Pondel of Pondel Parsons & Wilkinson, 310-207-9300, for Biopool International/
 (BIPL)


CO: Biopool International Inc. ST: California IN: MTC SU:

LS-JL -- LA008 -- 9414 03/25/93 09:13 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 25, 1993
Words:288
Previous Article:CMS ENHANCEMENTS EXTENDS HARD DISK WARRANTIES AND OFFERS LABOR REIMBURSEMENT TO DEALERS
Next Article:LOGICON ANNOUNCES NEW LMDS GRAPHICAL USER INTERFACE


Related Articles
BIOPOOL RECEIVES TWO NEW PATENTS
BIOPOOL ENTERS INTO DISTRIBUTION AGREEMENT FOR CHINA
BIOPOOL REPORTS RECORD YEAR-END RESULTS
BIOPOOL ANNOUNCES JAPANESE MINISTRY OF HEALTH AND WELFARE APPROVAL FOR DIAGNOSTIC KIT
BIOPOOL TEST KIT POINTS TO t-PA AS INDICATOR FOR HEART ATTACK RISK; HARVARD STUDY PUBLISHED IN LANCET
BIOPOOL REPORTS FIRST QUARTER RESULTS AND FIFTH CONSECUTIVE PROFITABLE QUARTER
BIOPOOL COMPLETES FINANCING
BICK ELECTED CHAIRMAN OF BOARD, KAUFMAN ELECTED BOARD MEMBER OF BIOPOOL
BIOPOOL POSTS SECOND QUARTER OPERATING RESULTS
BIOPOOL RECEIVES FDA APPROVAL FOR THERAPEUTIC DRUG MONITORING CONTROL

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters